Literature DB >> 18550427

Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus.

Anuradha Guggilam1, Kaushik P Patel, Masudul Haque, Philip J Ebenezer, Daniel R Kapusta, Joseph Francis.   

Abstract

OBJECTIVE: To investigate evidence for the interplay between cytokines, angiotensin II and nNOS in the paraventricular nucleus (PVN), for regulating sympathetic outflow in a rat model of CHF. METHODS AND
RESULTS: Heart failure was induced in Sprague-Dawley rats by coronary artery ligation. One group of rats was treated with pentoxifylline (PTX, 30 mg/kg IP), a cytokine blocker, or vehicle, for 5 weeks. Another group of rats was pre-treated with PTX before coronary ligation to study prior cytokine blocking effect on survival. Both groups were combined in the analysis. Echocardiography demonstrated an increase in LV end-diastolic pressure and Tei index after 5 weeks in CHF rats. ELISA revealed a significant increase in plasma TNF-alpha and IL-1beta in CHF rats. Inducible NOS (iNOS) and angiotensin receptor-type 1 (AT-1R) mRNA expressions were increased, while neuronal NOS (nNOS) was decreased in the PVN of CHF rats; these changes were reversed by PTX. PTX treatment also decreased plasma norepinephrine and epinephrine levels and improved baroreflex control of renal sympathoexcitation in CHF rats. Immunohistochemistry revealed elevated 3-nitrotyrosine formation in the heart and the PVN of CHF rats, but not in PTX treated rats.
CONCLUSION: PTX decreased both peripheral and central cytokine expression, alleviated nitric oxide dysregulation, and inhibited the formation of peroxynitrite in the PVN resulting in decreased sympathoexcitation in CHF rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550427      PMCID: PMC2593148          DOI: 10.1016/j.ejheart.2008.05.004

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  30 in total

Review 1.  Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain.

Authors:  Linda R Watkins; Erin D Milligan; Steven F Maier
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

Review 2.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

3.  Inflammatory mediators in chronic heart failure: an overview.

Authors:  Stefan D Anker; Stephan von Haehling
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

4.  Baroreceptor denervation profoundly enhances cardiovascular responses to central angiotensin II.

Authors:  K W Barron; A J Trapani; F J Gordon; M J Brody
Journal:  Am J Physiol       Date:  1989-07

5.  Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).

Authors:  G S Francis; C Benedict; D E Johnstone; P C Kirlin; J Nicklas; C S Liang; S H Kubo; E Rudin-Toretsky; S Yusuf
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

6.  Acute myocardial infarction induces hypothalamic cytokine synthesis.

Authors:  Joseph Francis; Yi Chu; Alan Kim Johnson; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-06       Impact factor: 4.733

7.  Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure.

Authors:  Joseph Francis; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11       Impact factor: 4.733

8.  New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function--a study in normals and dilated cardiomyopathy.

Authors:  C Tei; L H Ling; D O Hodge; K R Bailey; J K Oh; R J Rodeheffer; A J Tajik; J B Seward
Journal:  J Cardiol       Date:  1995-12       Impact factor: 3.159

9.  Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen.

Authors:  Hao Wang; Bing S Huang; Detlev Ganten; Frans H H Leenen Leenen
Journal:  Circ Res       Date:  2004-04-02       Impact factor: 17.367

10.  Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats.

Authors:  Joseph Francis; Terry Beltz; Alan Kim Johnson; Robert B Felder
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-12       Impact factor: 3.619

View more
  44 in total

1.  Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.

Authors:  Yu-Ming Kang; Ai-Qun Zhang; Xiu-Fang Zhao; Jeffrey P Cardinale; Carrie Elks; Xi-Mei Cao; Zhen-Wen Zhang; Joseph Francis
Journal:  Basic Res Cardiol       Date:  2011-02-02       Impact factor: 17.165

2.  TNF-α receptor 1 knockdown in the subfornical organ ameliorates sympathetic excitation and cardiac hemodynamics in heart failure rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

Review 3.  The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction.

Authors:  Bing S Huang; Frans H H Leenen
Journal:  Curr Heart Fail Rep       Date:  2009-06

4.  Interaction between interleukin-1 beta and angiotensin II receptor 1 in hypothalamic paraventricular nucleus contributes to progression of heart failure.

Authors:  Qiang Liu; Tao Wang; Huapeng Yu; Bin Liu; Ruyi Jia
Journal:  J Interferon Cytokine Res       Date:  2014-06-23       Impact factor: 2.607

5.  Exercise with angina and cramp?

Authors:  Julian F R Paton
Journal:  J Physiol       Date:  2011-01-15       Impact factor: 5.182

6.  Central SDF-1/CXCL12 expression and its cardiovascular and sympathetic effects: the role of angiotensin II, TNF-α, and MAP kinase signaling.

Authors:  Shun-Guang Wei; Zhi-Hua Zhang; Yang Yu; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

7.  Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity.

Authors:  Ding Zhao; Belinda H McCully; Virginia L Brooks
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

8.  Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current.

Authors:  Nan Jiang; Peng Shi; Fiona Desland; M Cristina Kitchen-Pareja; Colin Sumners
Journal:  Am J Physiol Cell Physiol       Date:  2013-02-20       Impact factor: 4.249

9.  Sex differences in the central and peripheral manifestations of ischemia-induced heart failure in rats.

Authors:  Yang Yu; Shun-Guang Wei; Robert M Weiss; Robert B Felder
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-10-05       Impact factor: 4.733

Review 10.  Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.

Authors:  Daniel M Hirai; Timothy I Musch; David C Poole
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-28       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.